Clinical Trials Browser

Unknown × Hematologic Neoplasms × Melphalan × Clear all

NCT05084027 2021-10-27

Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT

Phase 2 Unknown

Other hematologic neoplasm

Hematologic Neoplasms